Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 2
Submit an article Journal homepage
6,034
Views
129
CrossRef citations to date
0
Altmetric
Original Research

Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity

Yongkui LiResearch Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Min FangResearch Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Jian ZhangResearch Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Jian WangResearch Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Yu SongResearch Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Jie ShiResearch Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Wei LiResearch Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;Department of Surgery, University of Michigan School of Medicine, Ann Arbor, MI, USA
,
Gang WuCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Jinghua RenCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Zheng WangResearch Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;Department of Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
,
Weiping ZouDepartment of Surgery, University of Michigan School of Medicine, Ann Arbor, MI, USA
&
Lin WangResearch Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;Medical Research Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaCorrespondence[email protected]
 show all
Article: e1074374 | Received 13 Apr 2015, Accepted 15 Jul 2015, Published online: 26 Feb 2016

Citations (129)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Yun Wang, Long Cui, Peter Georgiev, Latika Singh, Yanyan Zheng, Ying Yu, Jeff Grein, Chunsheng Zhang, Eric S. Muise, David L. Sloman, Heidi Ferguson, Hongshi Yu, Cristina St. Pierre, Pranal J Dakle, Vincenzo Pucci, James Baker, Andrey Loboda, Doug Linn, Christopher Brynczka, Doug Wilson, Brian B Haines, Brian Long, Richard Wnek, Svetlana Sadekova, Michael Rosenzweig, Andrew Haidle, Yongxin Han & Sheila H. Ranganath. (2021) Combination of EP4 antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells. OncoImmunology 10:1.
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: TLR3 agonists in cancer therapy. OncoImmunology 9:1.
Read now
Fenghua Qian, Sougat Misra & K. Sandeep Prabhu. (2019) Selenium and selenoproteins in prostanoid metabolism and immunity. Critical Reviews in Biochemistry and Molecular Biology 54:6, pages 484-516.
Read now
Duy Hieu Truong, Thi Thu Phuong Tran, Hanh Thuy Nguyen, Cao Dai Phung, Tung Thanh Pham, Chul Soon Yong, Jong Oh Kim & Tuan Hiep Tran. (2019) Modulating T-cell-based cancer immunotherapy via particulate systems. Journal of Drug Targeting 27:2, pages 145-163.
Read now
Jieqing Li, Qiongyu Hao, Wei Cao, Jaydutt V Vadgama & Yong Wu. (2018) Celecoxib in breast cancer prevention and therapy. Cancer Management and Research 10, pages 4653-4667.
Read now
Dan A. Erkes, Nicole A. Wilski & Christopher M. Snyder. (2017) Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity. Human Vaccines & Immunotherapeutics 13:8, pages 1778-1785.
Read now

Articles from other publishers (123)

Khizra Mujahid, Isra Rana, Ivan Hardianto Suliman, Zhen Li, Jiang Wu, Huacheng He & Jutaek Nam. (2023) Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy. ACS Applied Bio Materials.
Crossref
Yongjing Cao, Juan Li, Qiangwei Liang, Jiayu Yang, Xiaojie Zhang, Juntao Zhang, Min An, Jiawei Bi & Yanhua Liu. (2023) Tumor Microenvironment Sequential Drug/Gene Delivery Nanosystem for Realizing Multistage Boosting of Cancer–Immunity Cycle on Cancer Immunotherapy. ACS Applied Materials & Interfaces 15:47, pages 54898-54914.
Crossref
April S. T. Marple, Alexander H. Jesmer, Ben P. M. Lake, Anthony F. Rullo & Ryan G. Wylie. (2023) A Modular Antibody‐Oligomer T Cell Engager for Applications in Local Therapies. Advanced Therapeutics 6:11.
Crossref
Sungyun Kim, Jae-Hee Ahn, Da In Jeong, Mingyu Yang, Jae-Hyeon Jeong, Yeoung Eun Choi, Hyun Jin Kim, Youngjoo Han, Mrinmoy Karmakar, Hyun-Jeong Ko & Hyun-Jong Cho. (2023) Alum-tuned hyaluronic acid-based hydrogel with immune checkpoint inhibition for immunophoto therapy of cancer. Journal of Controlled Release 362, pages 1-18.
Crossref
Amir Erfani, Antonio E. Diaz & Patrick S. Doyle. (2023) Hydrogel-enabled, local administration and combinatorial delivery of immunotherapies for cancer treatment. Materials Today 65, pages 227-243.
Crossref
Nikhil T. Sebastian, William A. Stokes, Madhusmita Behera, Renjian Jiang, David A. Gutman, Zhonglu Huang, Abigail Burns, Vidula Sukhatme, Michael C. Lowe, Suresh S. Ramalingam, Vikas P. Sukhatme & Drew Moghanaki. (2023) The Association of Improved Overall Survival with NSAIDs in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Clinical Lung Cancer 24:3, pages 287-294.
Crossref
Bixuan Li, Xi Ma, Jianghong Cheng, Tian Tian, Jiao Guo, Yang Wang & Long Pang. (2023) Droplets microfluidics platform—A tool for single cell research. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Raziyeh Zandvakili, Pedram Basirjafar, Javad Masoumi, Nahid Zainodini, Zahra Taghipour, Hossein Khorramdelazad, Soheila Yousefi, Tayyebeh Tavakoli, Sepehr Safdel, Mahsa Gheitasi, Fatemeh Ayoobi & Abdollah Jafarzadeh. (2023) Vaccination with celecoxib-treated dendritic cells improved cellular immune responses in an animal breast cancer model. Advances in Medical Sciences 68:1, pages 157-168.
Crossref
Enli Chen, Cong Wang, Hongwei Lv & Jing Yu. (2023) The role of fatty acid desaturase 2 in multiple tumor types revealed by bulk and single-cell transcriptomes. Lipids in Health and Disease 22:1.
Crossref
Palaniyandi Muthukutty, Hyun Woo, Murali Ragothaman & So Yoo. (2023) Recent Advances in Cancer Immunotherapy Delivery Modalities. Pharmaceutics 15:2, pages 504.
Crossref
Qing Kong, Mengyu Ma, Li Zhang, Suqing Liu, Shan He, Jinfeng Wu, Baojun Liu & Jingcheng Dong. (2023) Icariside II potentiates the anti-PD-1 antitumor effect by reducing chemotactic infiltration of myeloid-derived suppressor cells into the tumor microenvironment via ROS-mediated inactivation of the SRC/ERK/STAT3 signaling pathways. Phytomedicine 110, pages 154638.
Crossref
Ester Blanco, Luisa Chocarro, Leticia Fernández-Rubio, Ana Bocanegra, Hugo Arasanz, Miriam Echaide, Maider Garnica, Sergio Piñeiro-Hermida, Grazyna Kochan & David Escors. (2023) Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors. International Journal of Molecular Sciences 24:3, pages 2676.
Crossref
Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay & Ramish Maqsood. (2023) Review to Understand the Crosstalk between Immunotherapy and Tumor Metabolism. Molecules 28:2, pages 862.
Crossref
Simin Seyedpour & Nima Rezaei. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 25 .
Kyeong Jin Cho, Young-Eun Cho & Jihoon Kim. (2022) Locoregional Lymphatic Delivery Systems Using Nanoparticles and Hydrogels for Anticancer Immunotherapy. Pharmaceutics 14:12, pages 2752.
Crossref
Huayi Feng, Tao Wang, Jiali Ye, Yang Yang, Xing Huang, Dong Lai, Zheng Lv, Yan Huang & Xu Zhang. (2022) SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma. Discover Oncology 13:1.
Crossref
Nicholas Cunningham, Réjean Lapointe & Sophie Lerouge. (2022) Biomaterials for enhanced immunotherapy. APL Bioengineering 6:4.
Crossref
Armita Mahdavi Gorabi, Mehrnaz Sadat Ravari, Mohammad-Javad Sanaei, Soodabeh Davaran, Prashant Kesharwani & Amirhossein Sahebkar. (2022) Immune checkpoint blockade in melanoma: Advantages, shortcomings and emerging roles of the nanoparticles. International Immunopharmacology 113, pages 109300.
Crossref
Nicolas Roussot, François Ghiringhelli & Cédric Rébé. (2022) Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment. Cells 11:22, pages 3672.
Crossref
Yi Wang, Yuya Wang, Yifei Ren, Qi Zhang, Ping Yi & Chunming Cheng. (2022) Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer. Seminars in Cancer Biology 86, pages 542-565.
Crossref
Xuejiao Han, Aqu Alu, Hongmei Liu, Yi Shi, Xiawei Wei, Lulu Cai & Yuquan Wei. (2022) Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy. Bioactive Materials 17, pages 29-48.
Crossref
Ying Wang, Dan Wang, Li YangYi Zhang. (2022) Metabolic reprogramming in the immunosuppression of tumor-associated macrophages. Chinese Medical Journal 135:20, pages 2405-2416.
Crossref
Ramya Mathiyalagan, Anjali Kariyarath Valappil, Deok Chun Yang, Se Chan Kang & Thavasyappan Thambi. (2022) Gene Regulations upon Hydrogel-Mediated Drug Delivery Systems in Skin Cancers—An Overview. Gels 8:9, pages 560.
Crossref
Mohammad Arshad Javed Shaikh, Khalid Saad Alharbi, Waleed Hassan Almalki, Syed Sarim Imam, Mohammed Albratty, Abdulkarim M. Meraya, Sami I. Alzarea, Imran Kazmi, Fahad A. Al-Abbasi, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Yogendra Singh, Sachin Kumar Singh, Kamal Dua & Gaurav Gupta. (2022) Sodium alginate based drug delivery in management of breast cancer. Carbohydrate Polymers 292, pages 119689.
Crossref
Suyu Wang, Aona Chen, Wanli Zhu, Di Feng, Juan Wei, Quanfu Li, Xuan Shi, Xin Lv & Meiyun Liu. (2022) Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma. Frontiers in Genetics 13.
Crossref
Yaohua Ke, Junmeng Zhu, Yanhong Chu, Lanqi Cen, Yao Fu, Xiangshan Fan, Jingyi Shao, Rutian Li, Lixia Yu, Baorui Liu & Qin Liu. (2022) Bifunctional Fusion Membrane‐Based Hydrogel Enhances Antitumor Potency of Autologous Cancer Vaccines by Activating Dendritic Cells. Advanced Functional Materials 32:29.
Crossref
Hongbo Chen, Kai Hou, Jing Yu, Le Wang & Xue Chen. (2022) Nanoparticle-Based Combination Therapy for Melanoma. Frontiers in Oncology 12.
Crossref
Mina Aiad, Ali Tahir, Kayla Fresco, Zarian Prenatt, Karla Ramos-Feliciano, Jasmit Walia, Jill Stoltzfus & Heidar J Albandar. (2022) Does the Combined Use of Aspirin and Immunotherapy Result in Better Outcomes in Non-Small Cell Lung Cancer Than Immunotherapy Alone?. Cureus.
Crossref
Wei-Hai Chen, Qi-Wen Chen, Qian Chen, Chunyan Cui, Shun Duan, Yongyuan Kang, Yang Liu, Yun Liu, Wali Muhammad, Shiqun Shao, Chengqiang Tang, Jinqiang Wang, Lei Wang, Meng-Hua Xiong, Lichen Yin, Kuo Zhang, Zhanzhan Zhang, Xu Zhen, Jun Feng, Changyou Gao, Zhen Gu, Chaoliang He, Jian Ji, Xiqun Jiang, Wenguang Liu, Zhuang Liu, Huisheng Peng, Youqing Shen, Linqi Shi, Xuemei Sun, Hao Wang, Jun Wang, Haihua Xiao, Fu-Jian Xu, Zhiyuan Zhong, Xian-Zheng Zhang & Xuesi Chen. (2022) Biomedical polymers: synthesis, properties, and applications. Science China Chemistry 65:6, pages 1010-1075.
Crossref
Shun‐Yu Wu, Fu‐Gen Wu & Xiaoyuan Chen. (2022) Antibody‐Incorporated Nanomedicines for Cancer Therapy. Advanced Materials 34:24.
Crossref
YiTing Bai, TianRan Wang, SongLing Zhang, XueSi Chen & ChaoLiang He. (2022) Recent advances in organic and polymeric carriers for local tumor chemo-immunotherapy. Science China Technological Sciences 65:5, pages 1011-1028.
Crossref
Sheetal SharmaJigar VyasUmesh Upadhyay. (2022) Herbal extracts in Novel Drug Delivery System: A Magical Combo: A Brief Review. Research Journal of Pharmaceutical Dosage Forms and Technology, pages 150-156.
Crossref
Peng Liao, Weimin Wang, Weichao Wang, Ilona Kryczek, Xiong Li, Yingjie Bian, Amanda Sell, Shuang Wei, Sara Grove, Jeffrey K. Johnson, Paul D. Kennedy, Miguel Gijón, Yatrik M. Shah & Weiping Zou. (2022) CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40:4, pages 365-378.e6.
Crossref
Yushuai Liu, Yuanyuan Geng, Beilei Yue, Pui-Chi Lo, Jing Huang & Honglin Jin. (2022) Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment. Frontiers in Immunology 12.
Crossref
Karan Kohli, Venu G. Pillarisetty & Teresa S. Kim. (2021) Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Therapy 29:1, pages 10-21.
Crossref
Sina Taefehshokr, Aram Parhizkar, Shima Hayati, Morteza Mousapour, Amin Mahmoudpour, Liliane Eleid, Dara Rahmanpour, Sahand Fattahi, Hadi Shabani & Nima Taefehshokr. (2022) Cancer immunotherapy: Challenges and limitations. Pathology - Research and Practice 229, pages 153723.
Crossref
Ashleigh Hope, Samantha J. Wade, Morteza Aghmesheh & Kara L. Vine. (2022) Localized delivery of immunotherapy via implantable scaffolds for breast cancer treatment. Journal of Controlled Release 341, pages 399-413.
Crossref
Catarina Pacheco, Ana Baião, Flávia Sousa & Bruno Sarmento. 2022. Long-Acting Drug Delivery Systems. Long-Acting Drug Delivery Systems 129 162 .
Yongkui Li, Ying Huang, Pan Pan, Xu Che, Yaru Zhang, Yeshun Zhang, Algahtany Amal, Xin Li, Wenjing Niu, Nachuan Luo, Wen Zhang, Daolong Gao, Qiuping Tan, Qiwei Zhang, Xiwen Xing, Zhen Luo & Jianguo Wu. (2021) Sericin and sericin-derived peptide alleviate viral pathogenesis in mice though inhibiting lactate production and facilitating antiviral response. Applied Materials Today 25, pages 101256.
Crossref
Christine P. Carney, Nikhil Pandey, Anshika Kapur, Graeme F. Woodworth, Jeffrey A. Winkles & Anthony J. Kim. (2021) Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases. Drug Delivery and Translational Research 11:6, pages 2344-2370.
Crossref
Ritika Luthra, Shreeja Datta & Arpita Roy. (2021) Role of Different Peptides for Cancer Immunotherapy. International Journal of Peptide Research and Therapeutics 27:4, pages 2777-2793.
Crossref
Victoria S. Pelly, Agrin Moeini, Lisanne M. Roelofsen, Eduardo Bonavita, Charlotte R. Bell, Colin Hutton, Adrian Blanco-Gomez, Antonia Banyard, Christian P. Bromley, Eimear Flanagan, Shih-Chieh Chiang, Claus Jørgensen, Ton N. Schumacher, Daniela S. Thommen & Santiago Zelenay. (2021) Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy. Cancer Discovery 11:10, pages 2602-2619.
Crossref
David S. Monahan, Talal Almas, Robert Wyile, Faisal H. Cheema, Garry P. Duffy & Aamir Hameed. (2021) Towards the use of localised delivery strategies to counteract cancer therapy–induced cardiotoxicities. Drug Delivery and Translational Research 11:5, pages 1924-1942.
Crossref
Santiago Correa, Abigail K. Grosskopf, Hector Lopez Hernandez, Doreen Chan, Anthony C. Yu, Lyndsay M. Stapleton & Eric A. Appel. (2021) Translational Applications of Hydrogels. Chemical Reviews 121:18, pages 11385-11457.
Crossref
Jinhua Liu, Zichao Chen, Yaqun Li, Wenjie Zhao, JiBiao Wu & Zhen Zhang. (2021) PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy. Frontiers in Pharmacology 12.
Crossref
Yuping Zhao, Muhammad Bilal, Maimoona Qindeel, Muhammad Imran Khan, Kuldeep Dhama & Hafiz M. N. Iqbal. (2021) Nanotechnology-based immunotherapies to combat cancer metastasis. Molecular Biology Reports 48:9, pages 6563-6580.
Crossref
Yifeng Xia, Jingjing Wei, Songsong Zhao, Beibei Guo, Fenghua Meng, Bert Klumperman & Zhiyuan Zhong. (2021) Systemic administration of polymersomal oncolytic peptide LTX-315 combining with CpG adjuvant and anti-PD-1 antibody boosts immunotherapy of melanoma. Journal of Controlled Release 336, pages 262-273.
Crossref
Jun‐Long Liang, Guo‐Feng Luo, Wei‐Hai Chen & Xian‐Zheng Zhang. (2021) Recent Advances in Engineered Materials for Immunotherapy‐Involved Combination Cancer Therapy. Advanced Materials 33:31.
Crossref
Joviana Farhat, Ishan Pandey & Mohammad AlWahsh. (2021) Transcending toward Advanced 3D-Cell Culture Modalities: A Review about an Emerging Paradigm in Translational Oncology. Cells 10:7, pages 1657.
Crossref
Hongyu Ma, Chaoliang He & Xuesi Chen. (2021) Injectable Hydrogels as Local Depots at Tumor Sites for Antitumor Immunotherapy and Immune‐Based Combination Therapy. Macromolecular Bioscience 21:6.
Crossref
Zongyu Xie, Junjian Shen, Haitao Sun, Jingchao Li & Xiaojing Wang. (2021) Polymer-based hydrogels with local drug release for cancer immunotherapy. Biomedicine & Pharmacotherapy 137, pages 111333.
Crossref
Jie Zhou, Chao Wan, Jing Cheng, Hao Huang, Jonathan F. Lovell & Honglin Jin. (2021) Delivery Strategies for Melittin-Based Cancer Therapy. ACS Applied Materials & Interfaces 13:15, pages 17158-17173.
Crossref
Minsu Kwon, Hanul Jung, Gi-Hoon Nam & In-San Kim. (2021) The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy. Journal of Controlled Release 331, pages 321-334.
Crossref
Xiangyi Kong, Ran Cheng, Jing Wang, Yi Fang & Kuo Chu Hwang. (2021) Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications. Nano Today 36, pages 101004.
Crossref
Mei Zhang, Xianfeng Chen & Norbert Radacsi. (2021) New tricks of old drugs: Repurposing non-chemo drugs and dietary phytochemicals as adjuvants in anti-tumor therapies. Journal of Controlled Release 329, pages 96-120.
Crossref
Qiutong Jin, Zhuang Liu & Qian Chen. (2021) Controlled release of immunotherapeutics for enhanced cancer immunotherapy after local delivery. Journal of Controlled Release 329, pages 882-893.
Crossref
Mohammad-Javad Sanaei, Atieh Pourbagheri-Sigaroodi, Vahid Kaveh, Seyed Amir Sheikholeslami, Sina Salari & Davood Bashash. (2021) The application of nano-medicine to overcome the challenges related to immune checkpoint blockades in cancer immunotherapy: Recent advances and opportunities. Critical Reviews in Oncology/Hematology 157, pages 103160.
Crossref
Doudou Hu, Wei Zhang, Jianbin Tang, Zhuxian Zhou, Xiangrui Liu & Youqing Shen. (2021) Improving safety of cancer immunotherapy via delivery technology. Biomaterials 265, pages 120407.
Crossref
Seung Mo Jin, Sang Nam Lee, Hong Sik Shin & Yong Taik Lim. 2021. Nanoparticle-Mediated Immunotherapy. Nanoparticle-Mediated Immunotherapy 143 172 .
Chuanhui Han, Anli Zhang, Zhida Liu, Casey Moore & Yang-Xin Fu. (2020) Small molecular drugs reshape tumor microenvironment to synergize with immunotherapy. Oncogene.
Crossref
Weiwei Mu, Qihui Chu, Yongjun Liu & Na Zhang. (2020) A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy. Nano-Micro Letters 12:1.
Crossref
Jiacheng Wang, Haitian Zhao, Wenshu Qiao, Jianjun Cheng, Ying Han & Xin Yang. (2020) Nanomedicine-Cum-Carrier by Co-Assembly of Natural Small Products for Synergistic Enhanced Antitumor with Tissues Protective Actions. ACS Applied Materials & Interfaces 12:38, pages 42537-42550.
Crossref
Chen Yang, Nicholas Thomas Blum, Jing Lin, Junle Qu & Peng Huang. (2020) Biomaterial scaffold-based local drug delivery systems for cancer immunotherapy. Science Bulletin 65:17, pages 1489-1504.
Crossref
Chengyi Liu, Tianke Zhang, Liqun Chen & Yue Chen. (2020) The choice of anti-tumor strategies based on micromolecules or drug loading function of biomaterials. Cancer Letters 487, pages 45-52.
Crossref
Asmita Banstola, Jee-Heon Jeong & Simmyung Yook. (2020) Immunoadjuvants for cancer immunotherapy: A review of recent developments. Acta Biomaterialia 114, pages 16-30.
Crossref
Peter Abdou, Zejun Wang, Qian Chen, Amanda Chan, Daojia R. Zhou, Vivienne Gunadhi & Zhen Gu. (2020) Advances in engineering local drug delivery systems for cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 12:5.
Crossref
Mingqiang HaoBeibei ChenXiaoyi ZhaoNana Zhao & Fu-Jian Xu. (2020) Organic/inorganic nanocomposites for cancer immunotherapy. Materials Chemistry Frontiers 4:9, pages 2571-2609.
Crossref
Augusto Bleve, Barbara Durante, Antonio Sica & Francesca Maria Consonni. (2020) Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad. International Journal of Molecular Sciences 21:16, pages 5845.
Crossref
Eleonora Russo, Angela Santoni & Giovanni Bernardini. (2020) Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer. Journal of Leukocyte Biology 108:2, pages 673-685.
Crossref
Xiuli Ding, Chen Peng, Yongkui Li, Jia Liu, Yu Song, Bo Cai, Mengxi Xiang, Jian Zhang, Zheng Wang & Lin Wang. (2020) Targeting Inhibition of Foxp3 by MMP2/9 Sensitive Short Peptide Linked P60 Fusion Protein 6(P60‐MMPs) to Enhance Antitumor Immunity. Macromolecular Bioscience 20:7.
Crossref
Hossein Bagheri, Mohammad Hossein Pourhanifeh, Maryam Derakhshan, Maryam Mahjoubin-Tehran, Faezeh Ghasemi, Shabnam Mousavi, Rouhollah Rafiei, Kazem Abbaszadeh-Goudarzi, Hamid Reza Mirzaei & Hamed Mirzaei. (2020) CXCL-10: a new candidate for melanoma therapy?. Cellular Oncology 43:3, pages 353-365.
Crossref
Annika C. Betzler, Marie-Nicole Theodoraki, Patrick J. Schuler, Johannes Döscher, Simon Laban, Thomas K. Hoffmann & Cornelia Brunner. (2020) NF-κB and Its Role in Checkpoint Control. International Journal of Molecular Sciences 21:11, pages 3949.
Crossref
C. Wyatt ShieldsIVIV, Lily Li‐Wen Wang, Michael A. Evans & Samir Mitragotri. (2019) Materials for Immunotherapy. Advanced Materials 32:13.
Crossref
Imran G. House, Peter Savas, Junyun Lai, Amanda X.Y. Chen, Amanda J. Oliver, Zhi L. Teo, Kirsten L. Todd, Melissa A. Henderson, Lauren Giuffrida, Emma V. Petley, Kevin Sek, Sherly Mardiana, Tuba N. Gide, Camelia Quek, Richard A. Scolyer, Georgina V. Long, James S. Wilmott, Sherene Loi, Phillip K. Darcy & Paul A. Beavis. (2020) Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. Clinical Cancer Research 26:2, pages 487-504.
Crossref
Izumi Yamaguchi, Kohei Nakajima, Kenji Shono, Yoshifumi Mizobuchi, Toshitaka Fujihara, Eiji Shikata, Tadashi Yamaguchi, Keiko Kitazato, Oltea Sampetrean, Hideyuki Saya & Yasushi Takagi. (2020) Downregulation of PD-L1 via FKBP5 by celecoxib augments antitumor effects of PD-1 blockade in a malignant glioma model. Neuro-Oncology Advances 2:1.
Crossref
Margaret P. Manspeaker & Susan N. Thomas. (2020) Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy. Advanced Drug Delivery Reviews 160, pages 19-35.
Crossref
Alexander J. Najibi & David J. Mooney. (2020) Cell and tissue engineering in lymph nodes for cancer immunotherapy. Advanced Drug Delivery Reviews 161-162, pages 42-62.
Crossref
Kinan Alhallak, Jennifer Sun, Barbara Muz & Abdel Kareem Azab. 2020. Biomaterials for Cancer Therapeutics. Biomaterials for Cancer Therapeutics 499 526 .
Md. Asadujjaman, Kwan Hyung Cho, Dong-Jin Jang, Joo-Eun Kim & Jun-Pil Jee. (2020) Nanotechnology in the arena of cancer immunotherapy. Archives of Pharmacal Research 43:1, pages 58-79.
Crossref
Mohammad A. I. Al-Hatamleh, Engku Nur Syafirah E.A.R., Jennifer C. Boer, Khalid Ferji, Jean-Luc Six, Xin Chen, Eyad Elkord, Magdalena Plebanski & Rohimah Mohamud. (2019) Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment. Cells 9:1, pages 33.
Crossref
Zhongwei Zhao, Liyun Zheng, Weiqian Chen, Wei Weng, Jingjing Song & Jiansong Ji. (2019) Delivery strategies of cancer immunotherapy: recent advances and future perspectives. Journal of Hematology & Oncology 12:1.
Crossref
Damian Maseda, Emanuela Ricciotti & Leslie J. Crofford. (2019) Prostaglandin regulation of T cell biology. Pharmacological Research 149, pages 104456.
Crossref
Wei Sun, Yang Du, Xiaolong Liang, Chunyao Yu, Junjie Fang, Wei Lu, Xiuyu Guo, Jie Tian, Yinhua Jin & Jianjun Zheng. (2019) Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer. Biomaterials 217, pages 119264.
Crossref
Yongjiang Li, Ciceron Ayala-Orozco, Pradipta Ranjan Rauta & Sunil Krishnan. (2019) The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective. Nanoscale 11:37, pages 17157-17178.
Crossref
Yongli Fan, Yongkui Li, Jian Zhang, Xiuli Ding, Jinyuan Cui, Guobin Wang, Zheng Wang & Lin Wang. (2019) Alginate Enhances Memory Properties of Antitumor CD8 + T Cells by Promoting Cellular Antioxidation . ACS Biomaterials Science & Engineering 5:9, pages 4717-4725.
Crossref
Yuefeng Yang, Weidong Xu, Di Peng, Hao Wang, Xiaoyan Zhang, Hua Wang, Fengjun Xiao, Yitan Zhu, Yuan Ji, Kamalakar Gulukota, Donald L. HelsethJr.Jr., Kathy A. Mangold, Megan Sullivan, Karen Kaul, Edward Wang, Bellur S. PrabhakarJinnan Li, Xuejie Wu, Lisheng Wang & Prem Seth. (2019) An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy. Human Gene Therapy 30:9, pages 1117-1132.
Crossref
Jianping Liu, Run Zhang & Zhi Ping Xu. (2019) Nanoparticle‐Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions. Small 15:32.
Crossref
Hathaichanok Phuengkham, Long Ren, Il Woo Shin & Yong Taik Lim. (2019) Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy. Advanced Materials 31:34.
Crossref
Wei Sang, Zhan Zhang, Yunlu Dai & Xiaoyuan Chen. (2019) Recent advances in nanomaterial-based synergistic combination cancer immunotherapy. Chemical Society Reviews 48:14, pages 3771-3810.
Crossref
Purushottam Lamichhane, Rahul Deshmukh, Julie Brown, Silvia Jakubski, Priyanka Parajuli, Todd Nolan, Dewan Raja, Mary Badawy, Thomas Yoon, Mark Zmiyiwsky & Narottam Lamichhane. (2019) Novel Delivery Systems for Checkpoint Inhibitors. Medicines 6:3, pages 74.
Crossref
Maxence O. Dellacherie, Bo Ri Seo & David J. Mooney. (2019) Macroscale biomaterials strategies for local immunomodulation. Nature Reviews Materials 4:6, pages 379-397.
Crossref
David G. Leach, Simon Young & Jeffrey D. Hartgerink. (2019) Advances in immunotherapy delivery from implantable and injectable biomaterials. Acta Biomaterialia 88, pages 15-31.
Crossref
Di Wen, Guojun Chen, Qian Chen, Peter Y. Li, Hao Cheng & Zhen Gu. (2019) Engineering Protein Delivery Depots for Cancer Immunotherapy. Bioconjugate Chemistry 30:3, pages 515-524.
Crossref
Vincent Huynh, Alexander H. Jesmer, Muhammad M. Shoaib, Anthony D. D'Angelo, Anthony F. Rullo & Ryan G. Wylie. (2019) Improved Efficacy of Antibody Cancer Immunotherapeutics through Local and Sustained Delivery. ChemBioChem 20:6, pages 747-753.
Crossref
Kazuto Fukunaga, Hiroshi Tsutsumi & Hisakazu Mihara. (2019) Self-Assembling Peptides as Building Blocks of Functional Materials for Biomedical Applications. Bulletin of the Chemical Society of Japan 92:2, pages 391-399.
Crossref
Ningqiang Gong, Yuxuan Zhang, Zhen Zhang, Xianlei Li & Xing‐Jie Liang. (2018) Functional Nanomaterials Optimized to Circumvent Tumor Immunological Tolerance. Advanced Functional Materials 29:3.
Crossref
Masahiro Shibata, Kendall Ham & Mohammad Obaidul Hoque. (2018) A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy. International Journal of Cancer 143:9, pages 2133-2144.
Crossref
Jodie M. Fleming, Susan T. Yeyeodu, Ashley McLaughlin, Darren Schuman & Darlene K. Taylor. (2018) In Situ Drug Delivery to Breast Cancer-Associated Extracellular Matrix . ACS Chemical Biology 13:10, pages 2825-2840.
Crossref
Farideh Ordikhani, Mayuko Uehara, Vivek Kasinath, Li Dai, Siawosh K. Eskandari, Baharak Bahmani, Merve Yonar, Jamil R. Azzi, Yousef Haik, Peter T. Sage, George F. Murphy, Nasim Annabi, Tobias Schatton, Indira Guleria & Reza Abdi. (2018) Targeting antigen-presenting cells by anti–PD-1 nanoparticles augments antitumor immunity. JCI Insight 3:20.
Crossref
Nidhi Sinha, Nikita Subedi & Jurjen Tel. (2018) Integrating Immunology and Microfluidics for Single Immune Cell Analysis. Frontiers in Immunology 9.
Crossref
Ahmed S AbdElhamid, Dina G Zayed, Maged W Helmy, Shaker M Ebrahim, Mohammed Bahey-El-Din, Esmat A Zein-El-Dein, Sanaa A El-Gizawy & Ahmed O Elzoghby. (2018) Lactoferrin-tagged quantum dots-based theranostic nanocapsules for combined COX-2 inhibitor/herbal therapy of breast cancer. Nanomedicine 13:20, pages 2637-2656.
Crossref
Qian Chen, Chao Wang, Guojun Chen, Quanyin Hu & Zhen Gu. (2018) Delivery Strategies for Immune Checkpoint Blockade. Advanced Healthcare Materials 7:20, pages 1800424.
Crossref
Xinyu Yan, Shouyue Zhang, Yun Deng, Peiqi Wang, Qianqian Hou & Heng Xu. (2018) Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences. Frontiers in Pharmacology 9.
Crossref
Hirotake Tsukamoto, Koji Fujieda, Azusa Miyashita, Satoshi Fukushima, Tokunori Ikeda, Yosuke Kubo, Satoru Senju, Hironobu Ihn, Yasuharu Nishimura & Hiroyuki Oshiumi. (2018) Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment. Cancer Research 78:17, pages 5011-5022.
Crossref
Hua Wang & David J. Mooney. (2018) Biomaterial-assisted targeted modulation of immune cells in cancer treatment. Nature Materials 17:9, pages 761-772.
Crossref
Qin Fan, Zhipeng Chen, Chao Wang & Zhuang Liu. (2018) Toward Biomaterials for Enhancing Immune Checkpoint Blockade Therapy. Advanced Functional Materials 28:37, pages 1802540.
Crossref
Pengxiang Yang, Huijuan Song, Yibo Qin, Pingsheng Huang, Chuangnian Zhang, Deling Kong & Weiwei Wang. (2018) Engineering Dendritic-Cell-Based Vaccines and PD-1 Blockade in Self-Assembled Peptide Nanofibrous Hydrogel to Amplify Antitumor T-Cell Immunity. Nano Letters 18:7, pages 4377-4385.
Crossref
Ahmed S AbdElhamid, Maged W Helmy, Shaker M Ebrahim, Mohammed Bahey-El-Din, Dina G Zayed, Esmat A Zein El Dein, Sanaa A El-Gizawy & Ahmed O Elzoghby. (2018) Layer-by-layer gelatin/chondroitin quantum dots-based nanotheranostics: combined rapamycin/celecoxib delivery and cancer imaging. Nanomedicine 13:14, pages 1707-1730.
Crossref
Yu‐Qing Xie, Lixia Wei & Li Tang. (2018) Immunoengineering with biomaterials for enhanced cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 10:4.
Crossref
Zhiting Sun, Jie Liang, Xia Dong, Chun Wang, Deling Kong & Feng Lv. (2018) Injectable Hydrogels Coencapsulating Granulocyte-Macrophage Colony-Stimulating Factor and Ovalbumin Nanoparticles to Enhance Antigen Uptake Efficiency. ACS Applied Materials & Interfaces 10:24, pages 20315-20325.
Crossref
Honglin Jin, Chao Wan, Zhenwei Zou, Guifang Zhao, Lingling Zhang, Yuanyuan Geng, Tong Chen, Ai Huang, Fagang Jiang, Jue-Ping Feng, Jonathan F. Lovell, Jing Chen, Gang Wu & Kunyu Yang. (2018) Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel. ACS Nano 12:4, pages 3295-3310.
Crossref
Chun Gwon Park, Christina A. HartlDaniela Schmid, Ellese M. CarmonaHye-Jung KimMichael S. Goldberg. (2018) Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases. Science Translational Medicine 10:433.
Crossref
Ryuma Tokunaga, Wu Zhang, Madiha Naseem, Alberto Puccini, Martin D Berger, Shivani Soni, Michelle McSkane, Hideo Baba & Heinz-Josef Lenz. (2018) CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy. Cancer Treatment Reviews 63, pages 40-47.
Crossref
Wenhan Liu, Zejun Wang, Yao Luo & Nan Chen. (2017) Application of Nanocomposites in Cancer Immunotherapy. Nano LIFE 07:03n04, pages 1750008.
Crossref
Jie Miao, Xu Lu, Yuefeng Hu, Chunmei Piao, Xuan Wu, Xuesong Liu, Caiting Huang, Yue Wang, Dan Li & Jingwei Liu. (2017) Prostaglandin E2 and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment. Oncotarget 8:52, pages 89802-89810.
Crossref
Guoyou Huang, Fei Li, Xin Zhao, Yufei Ma, Yuhui Li, Min Lin, Guorui Jin, Tian Jian Lu, Guy M. Genin & Feng Xu. (2017) Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment. Chemical Reviews 117:20, pages 12764-12850.
Crossref
Hui Qiu, Yuanzeng Min, Zach Rodgers, Longzhen Zhang & Andrew Z. Wang. (2017) Nanomedicine approaches to improve cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 9:5.
Crossref
Chao Wang, Yanqi Ye, Quanyin Hu, Adriano Bellotti & Zhen Gu. (2017) Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook. Advanced Materials 29:29, pages 1606036.
Crossref
Min Fang, Yongkui Li, Kai Huang, Shanshan Qi, Jian Zhang, Witold Zgodzinski, Marek Majewski, Grzegorz Wallner, Stanislaw Gozdz, Pawel Macek, Artur Kowalik, Marcin Pasiarski, Ewelina Grywalska, Linda Vatan, Nisha Nagarsheth, Wei Li, Lili Zhao, Ilona Kryczek, Guobin Wang, Zheng Wang, Weiping Zou & Lin Wang. (2017) IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment. Cancer Research 77:10, pages 2735-2745.
Crossref
David M. Francis & Susan N. Thomas. (2017) Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy. Advanced Drug Delivery Reviews 114, pages 33-42.
Crossref
Ok Park, Gyeonghui Yu, Heejung Jung & Hyejung Mok. (2016) Recent studies on micro-/nano-sized biomaterials for cancer immunotherapy. Journal of Pharmaceutical Investigation 47:1, pages 11-18.
Crossref
Jeffrey L. Wong, Nataša Obermajer, Kunle Odunsi, Robert P. Edwards & Pawel Kalinski. (2016) Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor Microenvironment. Cancer Immunology Research 4:4, pages 303-311.
Crossref
Weiping ZouJedd D. WolchokLieping Chen. (2016) PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Science Translational Medicine 8:328.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.